Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2002

View Archived Issues

Pharming and GTC enter crosslicense agreement

Schering AG and Neurosciences Victoria sign neuroscience research collaboration

Pharmacopeia identifies lead series of compounds in Organon collaboration

Snapshots on thiazolidinediones at ENDO 2002

Novel antiplatelet agent discovered and characterized at Yamanouchi

Ro-25-4020: mechanism underlying enhanced anticancer properties compared to 1,25(OH)2D3

ACAT inhibitor with promising hypocholesterolemic effects under investigation at Sumitomo

Dual alpha/beta-adrenoceptor blocker and vasodilator characterized by Chinese group

The lipid-lowering effects of a combination of raloxifene and simvastatin

New oxytocin antagonists reported by Mitsubishi Pharma

Almirall Prodesfarma claims novel antihistaminic compounds

Adenovirus-mediated Apoptin gene transfer specifically kills tumor cells

Novel 5-HT2C agonists for use in obesity and psychiatric disorders

TPP-II inhibitors in early development at Janssen

Researchers at Allergan identify inhibitors of P-450RAI

Merck presents new alpha1A-adrenoceptor antagonists for BPH

Inhibitors of gamma-secretase in development at Merck & Co.

Nonsteroidal SERM with antiestrogenic effects in breast cancer cells, little uterotrophic liability

CPMP issues positive opinion reaffirming favorable risk/benefit profile of Reductil/Meridia

Noven files MethyPatch NDA for ADHD

Esperion initiates phase II study of ETC-588 in vascular disease

Calcimimetic AMG-073 may improve outcomes in patients with ESRD

Periostat receives final marketing approvals in Portugal and The Netherlands

Tariquidar enters phase III for multidrug-resistant NSCLC

Phase I/II follow-up data for GVAX lung cancer vaccine

Zevalin European launch delayed

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...